NEW YORK, NY--(Marketwired - Apr 18, 2016) - Tauriga Sciences, Inc. (
For example, an investor who invested $10,000 USD in this financing round received 2,500,000 shares of common stock and the 1,000,000 warrant to purchase 1,000,000 shares of common stock at $0.01 for a period of three years. In aggregate, the Company issued 26,375,000 shares of common stock and warrants for an additional 10,550,000 shares of common stock as part of the financing. All shares issued and to be issued will be "restricted securities" as such term is defined by the Securities Act of 1933, as amended.
The proceeds from this private placement will be used for working capital purposes, most specifically to fund the Company's ongoing litigation against Cowan Gunsteski Co. P.A., satisfy the financial obligations to Tauriga's new auditor under the updated terms on the recently signed engagement letter, settle some additional outstanding obligations and establish new business opportunities for Pilus Energy LLC.
Tauriga's CEO Mr. Seth M. Shaw expressed, "The Company is pleased to have completed this equity private placement which has provided Tauriga with the working capital requisite to expedite some important corporate initiatives. The Company continues to work diligently in its efforts to regain its status as a fully reporting Company and continues to make meaningful progress with respect to a number of other important goals."
About TAURIGA SCIENCES, INC.:
Tauriga Sciences, Inc. (
NON SOLICITATION:
This press release does not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor will there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale is not permitted. Any securities offered or issued in connection with the above-referenced merger and/or investment have not been registered, and will be offered pursuant to an exemption from registration.
DISCLAIMER:
Forward-Looking Statements:
This release contains the Company's forward-looking statements which are based on management's current expectations and assumptions as of April 5, 2016, regarding the Company's business and performance, its prospects, current factors, the economy and other future conditions and forecasts of future events, circumstances and results.
Contact Information:
Contact:
Tauriga Sciences, Inc.
Mr. Seth Shaw
CEO
Tel: 1-917-796-9926
Email: sshaw@tauriga.com